Extensive weight loss reveals distinct gene expression changes in human subcutaneous and visceral adipose tissue

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Mardinoglu, Adil ^a,b   Heiker, John T ^c   Gärtner, Daniel ^d   Björnson, Elias ^a   Schön, Michael R ^d   Flehmig, Gesine ^c   Klöting, Nora ^e   Krohn, Knut ^f   Fasshauer, Mathias ^c   Stumvoll, Michael ^c   Nielsen, Jens ^a,b   Blüher, Matthias ^c  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^e IFB Adiposity Diseases Junior Research Group 2 Animal models of obesity   (Germany)

^f UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET; TRANSCRIPTOME;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; BODY MASS; FEMALE; GASTRIC BYPASS SURGERY; HUMAN; INTRAABDOMINAL FAT; MALE; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PATHOLOGY; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; FEMALE; GASTRIC BYPASS; HUMANS; INTRA-ABDOMINAL FAT; LIPID DROPLETS; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; OBESITY, MORBID; SUBCUTANEOUS FAT, ABDOMINAL; TRANSCRIPTOME; WEIGHT LOSS;

EID: 84943328195     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14841     Document Type: Article

References (70)

1. de Onis, M., Blossner, M. & Borghi, E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr 92, 1257-1264 (2010).
2. Kimokoti, R. W. & Millen, B. E. Diet, the Global Obesity Epidemic, and Prevention. J Am Diet Assoc 111, 1137-1140 (2011).
3. Flegal, K. M., Graubard, B. I., Williamson, D. F. & Gail, M. H. Cause-specific excess deaths associated with underweight, overweight, and obesity. Jama 298, 2028-2037 (2007).
4. Schleinitz, D., Bottcher, Y., Bluher, M. & Kovacs, P. The genetics of fat distribution. Diabetologia 57, 1276-1286 (2014).
5. Lehr, S., Hartwig, S. & Sell, H. Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics Clin Appl 6, 91-101 (2012).
6. Bluher, M. Clinical relevance of adipokines. Diabetes Metab J 36, 317-327 (2012).
7. Anderson, J. W., Conley, S. B. & Nicholas, A. S. One hundred pound weight losses with an intensive behavioral program: changes in risk factors in 118 patients with long-Term follow-up. Am J Clin Nutr 86, 301-307 (2007).
8. Ross, R. et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 133, 92-103 (2000).
9. Knowler, W. C. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393-403 (2002).
10. Carvajal, R., Wadden, T. A., Tsai, A. G., Peck, K. & Moran, C. H. Managing obesity in primary care practice: a narrative review. Ann N Y Acad Sci 1281, 191-206 (2013).
11. Middleton, K. M., Patidar, S. M. & Perri, M. G. The impact of extended care on the long-Term maintenance of weight loss: a systematic review and meta-Analysis. Obes Rev 13, 509-517 (2012).
12. Nutrition ASfC. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 68, 899-917 (1998).
13. Sjostrom, L. et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357, 741-752 (2007).
14. Sjostrom, L. et al. Association of bariatric surgery with long-Term remission of type 2 diabetes and with microvascular and macrovascular complications. Jama 311, 2297-2304 (2014).
15. Sjostrom, L. Review of the key results from the Swedish Obese Subjects (SOS) trial-A prospective controlled intervention study of bariatric surgery. J Intern Med 273, 219-234 (2013).
16. Miras, A D. & le Roux, C. W. Can Medical Therapy Mimic the Clinical Efficacy or Physiological Effects of Bariatric Surgery? Int J Obesity 38, 325-333 (2014).
17. Sjoholm, K. et al. Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study. Diabetologia 58, 1448-1453 (2015).
18. Sjostrom, L. et al. Bariatric surgery and long-Term cardiovascular events. Jama 307, 56-65 (2012).
19. Lefebvre, A. M. et al. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47, 98-103 (1998).
20. Modesitt, S. C., Hsu, J. Y., Chowbina, S. R., Lawrence, R. T. & Hoehn, K. L. Not all fat is equal: differential gene expression and potential therapeutic targets in subcutaneous adipose, visceral adipose, and endometrium of obese women with and without endometrial cancer. Int J Gynecol Cancer 22, 732-741 (2012).
21. Gerhard, G. S. et al. Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity. Int J Obesity 38, 371-378 (2014).
22. Linder, K., Arner, P., Flores-Morales, A., Tollet-Egnell, P. & Norstedt, G. Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women. J Lipid Res 45, 148-154 (2004).
23. Kulyte, A. et al. MicroRNA profiling links miR-378 to enhanced adipocyte lipolysis in human cancer cachexia. Am J Physiol Endocrinol Metab 306, E267-274 (2014).
24. Taleb, S. et al. Microarray profiling of human white adipose tissue after exogenous leptin injection. Eur J Clin Invest 36, 153-163 (2006).
25. Marquez-Quinones, A. et al. Adipose tissue transcriptome reflects variations between subjects with continued weight loss and subjects regaining weight 6 mo after caloric restriction independent of energy intake. Am J Clin Nutr 92, 975-984 (2010).
26. Mardinoglu, A. et al. Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol Syst Biol 9, 649 (2013).
27. Agren, R. et al. Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT. Plos Comput Biol 8, e1002518 (2012).
28. Mardinoglu, A. & Nielsen, J. New paradigms for metabolic modeling of human cells. Curr Opin Biotech 34, 91-97 (2015).
29. Yizhak, K., Chaneton, B., Gottlieb, E. & Ruppin, E. Modeling cancer metabolism on a genome scale. Mol Syst Biol 11, 817 (2015).
30. O'Brien, E. J., Monk, J. M. & Palsson, B. O. Using Genome-scale Models to Predict Biological Capabilities. Cell 161, 971-987 (2015).
31. Mardinoglu, A., Gatto, F. & Nielsen, J. Genome-scale modeling of human metabolism-A systems biology approach. Biotechnol J 8, 985-996 (2013).
32. Shoaie, S. et al. Understanding the interactions between bacteria in the human gut through metabolic modeling. Sci Rep 3, 2532 (2013).
33. Mardinoglu, A. et al. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-Alcoholic fatty liver disease. Nat Commun 5, 3083 (2014).
34. Ghaffari, P. et al. Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling. Sci Rep 5, 8183 (2015).
35. Varemo, L. et al. Transcriptome and proteome driven reconstruction of the human myocyte metabolic model and its use for identification of metabolic markers for type 2 diabetes. Cell Rep 11, 921-933 (2015).
36. Yizhak, K., Gabay, O., Cohen, H. & Ruppin, E. Model-based identification of drug targets that revert disrupted metabolism and its application to ageing. Nat Commun 4, 2632 (2013).
37. Yizhak, K. et al. Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer. Elife 3, e03641 (2014).
38. Yizhak, K. et al. A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration. Mol Syst Biol 10, 744 (2014).
39. Galhardo, M. et al. Integrated analysis of transcript-level regulation of metabolism reveals disease-relevant nodes of the human metabolic network. Nucleic Acids Res 42, 1474-1496 (2014).
40. Zhang, C., Ji, B., Mardinoglu, A., Nielsen, J. & Hua, Q. Logical transformation of genome-scale metabolic models for gene level applications and analysis. Bioinformatics 31, 2324-2331 (2015).
41. Agren, R. et al. Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol Syst Biol 10, 721 (2014).
42. Gatto, F., Miess, H., Schulze, A. & Nielsen, J. Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism. Sci Rep 5, 10738 (2015).
43. Shoaie, S. et al. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab 22, 320-331 (2015).
44. Uhlen, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).
45. Fagerberg, L. et al. Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics. Mol Cell Proteomics 13, 397-406 (2014).
46. Uhlen, M. et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28, 1248-1250 (2010).
47. Kampf, C. et al. The human liver-specific proteome defined by transcriptomics and antibody-based profiling. Faseb J 28, 2901-2914 (2014).
48. Kampf, C. et al. Defining the human gallbladder proteome by transcriptomics and affinity proteomics. Proteomics 14, 2498-2507 (2014).
49. Lindskog, C. et al. The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling. Bmc Genomics 16, 475 (2015).
50. Mardinoglu, A. et al. Defining the human adipose tissue proteome to reveal metabolic alterations in obesity. J Proteome Res 13, 5106-5119 (2014).
51. Kannt, A. et al. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia 58, 799-808 (2015).
52. V'remo, L., Nielsen, J. & Nookaew, I. Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res 4, 4378-4391 (2013).
53. Houtkooper, R. H., Canto, C., Wanders, R. J. & Auwerx, J. The secret life of NAD+ : an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31, 194-223 (2010).
54. Furukawa, S. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752-1761 (2004).
55. Herzig, S. et al. Identification and functional expression of the mitochondrial pyruvate carrier. Science 337, 93-96 (2012).
56. Newgard, C. B. et al. A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance (vol 9, pg 311, 2009). Cell Metab 9, 565-566 (2009).
57. Puri, V. et al. Cidea is associated with lipid droplets and insulin sensitivity in humans. P Natl Acad Sci USA 105, 7833-7838 (2008).
58. Donkor, J., Sparks, L. M., Xie, H., Smith, S. R. & Reue, K. Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-Activated receptor alpha gene expression and insulin sensitivity in healthy young men. J Clin Endocrinol Metab 93, 233-239 (2008).
59. Zhou, Z. et al. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet 35, 49-56 (2003).
60. Gummesson, A. et al. Relations of adipose tissue CIDEA gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies. J Clin Endocrinol Metab 92, 4759-4765 (2007).
61. Viswakarma, N. et al. Transcriptional regulation of Cidea, mitochondrial cell death-inducing DNA fragmentation factor alphalike effector A, in mouse liver by peroxisome proliferator-Activated receptor alpha and gamma. J Biol Chem 282, 18613-18624 (2007).
62. Laurencikiene, J. et al. Evidence for an important role of CIDEA in human cancer cachexia. Cancer Res 68, 9247-9254 (2008).
63. Dahlman, I. et al. Adipose tissue pathways involved in weight loss of cancer cachexia. Brit J Cancer 102, 1541-1548 (2010).
64. Henegar, C. et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 9, R14 (2008).
65. Kolehmainen, M. et al. Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. Int J Obesity 32, 292-303 (2008).
66. Ryden, M. et al. Lipolysis-not inflammation, cell death, or lipogenesis-is involved in adipose tissue loss in cancer cachexia. Cancer 113, 1695-1704 (2008).
67. Clement, K. et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. Faseb J 18, 1657-1669 (2004).
68. Kloeting, N. et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-Abdominal fat mass. Cell Metab 6, 79-87 (2007).
69. Viguerie, N. et al. Determinants of human adipose tissue gene expression: impact of diet, sex, metabolic status, and cis genetic regulation. PLoS Genet 8, e1002959 (2012).
70. Mehta, R. et al. Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples. BMC Mol Biol 11, 39 (2010).